Literature DB >> 16676437

Ionizing radiation inhibits tumor neovascularization by inducing ineffective angiogenesis.

Jeff H Tsai1, Sosina Makonnen, Michael Feldman, Chandra M Sehgal, Amit Maity, William M F Lee.   

Abstract

The vascular effects of ionizing radiation were examined in K1735 murine melanoma tumors. Single-fraction and fractionated radiation virtually arrested growth of these tumors for about a week, after which they resumed more rapid growth. Tumor microvessel density (MVD) and blood perfusion was unchanged seven days after radiation but decreased at later time points after irradiation, when they had grown 10-fold or more. Together with the finding of severe tumor hypoxia and VEGF induction in the latter tumors, the evidence pointed to vascular insufficiency and inhibited neovascularization in tumors that had grown substantially after radiation. Endothelial cell (EC) death detected by TUNEL staining only transiently increased the day following radiation, whereas EC proliferation detected by Ki-67 staining was increased in irradiated tumors that had grown substantially. The fact that increased EC proliferative activity produced fewer vessels suggests that angiogenesis is defective or ineffective after radiation. These results complement recent genetic evidence that EC damage from radiation plays a major role in tissue damage and antitumor efficacy to highlight the importance of EC and vasculature in radiation response. Our studies further show that radiation impact on tumor vasculature extends beyond near-term induction of EC death to more prolonged effects on their ability to support angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16676437     DOI: 10.4161/cbt.4.12.2331

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  23 in total

1.  Loss of Pericytes in Radiation Necrosis after Glioblastoma Treatments.

Authors:  Soon-Tae Lee; Youngbeom Seo; Ji-Yeon Bae; Kon Chu; Jin Wook Kim; Seung Hong Choi; Tae Min Kim; Il Han Kim; Sung-Hye Park; Chul-Kee Park
Journal:  Mol Neurobiol       Date:  2017-08-02       Impact factor: 5.590

Review 2.  Effects of irradiation on tumor cell survival, invasion and angiogenesis.

Authors:  Odysseas Kargiotis; Aliki Geka; Jasti S Rao; Athanasios P Kyritsis
Journal:  J Neurooncol       Date:  2010-05-07       Impact factor: 4.130

3.  Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo.

Authors:  Frank Michael Klenke; Amir Abdollahi; Marc Bischof; Martha-Maria Gebhard; Volker Ewerbeck; Peter E Huber; Axel Sckell
Journal:  Strahlenther Onkol       Date:  2010-12-23       Impact factor: 3.621

4.  Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions.

Authors:  Alexander Filatenkov; Jeanette Baker; Antonia M S Mueller; Justin Kenkel; G-One Ahn; Suparna Dutt; Nigel Zhang; Holbrook Kohrt; Kent Jensen; Sussan Dejbakhsh-Jones; Judith A Shizuru; Robert N Negrin; Edgar G Engleman; Samuel Strober
Journal:  Clin Cancer Res       Date:  2015-04-13       Impact factor: 12.531

Review 5.  Opportunities and challenges of radiotherapy for treating cancer.

Authors:  Dörthe Schaue; William H McBride
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

6.  Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusion.

Authors:  Alexander Filatenkov; Jeanette Baker; Antonia M Müller; G-One Ahn; Holbrook Kohrt; Suparna Dutt; Kent Jensen; Sussan Dejbakhsh-Jones; Robert S Negrin; Judith A Shizuru; Edgar G Engleman; Samuel Strober
Journal:  Radiat Res       Date:  2014-07-03       Impact factor: 2.841

7.  Tie2 in tumor endothelial signaling and survival: implications for antiangiogenic therapy.

Authors:  Jeff H Tsai; William M F Lee
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

Review 8.  Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: experimental models and clinical perspectives.

Authors:  G-One Ahn; J Martin Brown
Journal:  Cell Cycle       Date:  2009-04-04       Impact factor: 4.534

9.  Radiogenic lymphangiogenesis in the skin.

Authors:  Susanne Jackowski; Matthias Janusch; Eckhard Fiedler; Wolfgang C Marsch; Eva J Ulbrich; Gabriele Gaisbauer; Jürgen Dunst; Dontscho Kerjaschki; Peter Helmbold
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

10.  Concurrent chemoradiotherapy with low-dose docetaxel inhibits the growth of DU-145 prostate cancer xenografts.

Authors:  L Wang; X Huang; X Zheng; X Wang; S Li; L Zhang; Z Yang
Journal:  Clin Transl Oncol       Date:  2013-10-09       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.